427 related articles for article (PubMed ID: 15725082)
41. [A retrospective analysis of 8 cases with primary central nervous system lymphoma].
Zhou XQ; Liu XQ; Kong JC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Oct; 23(5):455-7. PubMed ID: 12905861
[TBL] [Abstract][Full Text] [Related]
42. A single-center study of treatment outcomes and survival in patients with primary gastric lymphomas between 1990 and 2003.
Jezersek Novaković B; Vovk M; Juznic Setina T
Ann Hematol; 2006 Dec; 85(12):849-56. PubMed ID: 16944146
[TBL] [Abstract][Full Text] [Related]
43. [Primary malignant non-Hodgkin's lymphomas of the central nervous system in immunocompetent patients: diagnostic, prognostic and therapeutic criteria].
Ferracini R
Pathologica; 1997 Apr; 89(2):146-54. PubMed ID: 9411361
[TBL] [Abstract][Full Text] [Related]
44. Current management of primary central nervous system lymphoma.
Schultz CJ; Bovi J
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):666-78. PubMed ID: 20159361
[TBL] [Abstract][Full Text] [Related]
45. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
[TBL] [Abstract][Full Text] [Related]
46. Primary colorectal lymphomas.
Wong MT; Eu KW
Colorectal Dis; 2006 Sep; 8(7):586-91. PubMed ID: 16919111
[TBL] [Abstract][Full Text] [Related]
47. [Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases].
He YF; Zhang YJ; Li YH; Lin TY; Xia YF; Lu TX; Huang HQ; Jiang WQ; Xian CG; He YJ; Guan ZZ
Ai Zheng; 2006 Dec; 25(12):1538-42. PubMed ID: 17166382
[TBL] [Abstract][Full Text] [Related]
48. [Survival outcomes of T-cell non-Hodgkin's lymphoma: a report of 111 cases].
Huang Y; Lin TY; Wu QL; Su ZL; Huang HQ; Xia ZJ; Sun XF; Jiang WQ; Guan ZZ
Ai Zheng; 2005 Apr; 24(4):470-4. PubMed ID: 15820072
[TBL] [Abstract][Full Text] [Related]
49. Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis.
Ghesquières H; Berger F; Felman P; Callet-Bauchu E; Bryon PA; Traverse-Glehen A; Thieblemont C; Baseggio L; Michallet AS; Coiffier B; Salles G
J Clin Oncol; 2006 Nov; 24(33):5234-41. PubMed ID: 17043351
[TBL] [Abstract][Full Text] [Related]
50. [Response to chemotherapy in cerebral primary lymphoma].
García-Rayo S; Martínez-Monge R; Brugarolas A
Rev Neurol; 1998 Dec; 27(160):992-4. PubMed ID: 9951022
[TBL] [Abstract][Full Text] [Related]
51. New treatment approaches in primary central nervous system lymphoma.
Soussain C; Hoang-Xuan K; Doolittle ND
Hematol Oncol Clin North Am; 2005 Aug; 19(4):719-28, vii. PubMed ID: 16083832
[TBL] [Abstract][Full Text] [Related]
52. Secondary central nervous system involvement by follicular lymphoma: case report and review of the literature.
Grupka NL; Seinfeld J; Ryder J; Lillehei KO; Kleinschmidt-Demasters BK
Surg Neurol; 2006 Jun; 65(6):590-4. PubMed ID: 16720183
[TBL] [Abstract][Full Text] [Related]
53. [Clinical features of 89 patients with primary non-Hodgkin's lymphoma of the tonsil].
Qin Y; Shi YK; He XH; Yang JL; Yang S; Yu YX; Li B; Wang QL; Zhou LQ; Sun Y
Ai Zheng; 2006 Apr; 25(4):481-5. PubMed ID: 16613685
[TBL] [Abstract][Full Text] [Related]
54. Incidence, clinicopathological features and outcome of primary central nervous system lymphomas. Population-based data from a Danish lymphoma registry. Danish Lymphoma Study Group, LYFO.
Krogh-Jensen M; d'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Ann Oncol; 1994 Apr; 5(4):349-54. PubMed ID: 8075032
[TBL] [Abstract][Full Text] [Related]
55. Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire.
Soussain C; Hoang-Xuan K; Taillandier L; Fourme E; Choquet S; Witz F; Casasnovas O; Dupriez B; Souleau B; Taksin AL; Gisselbrecht C; Jaccard A; Omuro A; Sanson M; Janvier M; Kolb B; Zini JM; Leblond V;
J Clin Oncol; 2008 May; 26(15):2512-8. PubMed ID: 18413641
[TBL] [Abstract][Full Text] [Related]
56. Analysis of local control in patients with non-Hodgkin's lymphoma according to the WHO classification.
Sakata K; Satoh M; Someya M; Nagakura H; Oouchi A; Nakata K; Kogawa K; Koito K; Hareyama M; Himi T
Strahlenther Onkol; 2005 Jun; 181(6):385-91. PubMed ID: 15925981
[TBL] [Abstract][Full Text] [Related]
57. Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment.
Hormigo A; Abrey L; Heinemann MH; DeAngelis LM
Br J Haematol; 2004 Jul; 126(2):202-8. PubMed ID: 15238140
[TBL] [Abstract][Full Text] [Related]
58. Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma.
Gavrilovic IT; Hormigo A; Yahalom J; DeAngelis LM; Abrey LE
J Clin Oncol; 2006 Oct; 24(28):4570-4. PubMed ID: 17008697
[TBL] [Abstract][Full Text] [Related]
59. Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients.
Newell ME; Hoy JF; Cooper SG; DeGraaff B; Grulich AE; Bryant M; Millar JL; Brew BJ; Quinn DI
Cancer; 2004 Jun; 100(12):2627-36. PubMed ID: 15197806
[TBL] [Abstract][Full Text] [Related]
60. [Non-Hodgkin's lymphomas of the digestive tract and anexal glands in AIDS patients].
Corti M; Villafañe Fioti MF; Lewi D; Schtirbu R; Narbaitz M; de Dios Soler M
Acta Gastroenterol Latinoam; 2006 Dec; 36(4):190-6. PubMed ID: 17225446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]